The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease
NCT00214240
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Cytomegalovirus
Interventions
DRUG:
CMV Immune globulin
Sponsor
University of Wisconsin, Madison